Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Tomomitsu Matono · SciRah

Researcher profile · Semantic Scholar

Tomomitsu Matono

Share profile

Tomomitsu Matono — researcher profile on SciRah

h-index: 19
Works: 127
Citations: 1,174

Most-cited papers

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients
Masaki Maeda, I. Saeki, I. Sakaida, H. Aikata +27 more
2019Liver Cancer76 citations Open access
Semantic Scholar
Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules
Kohshiro Hosokawa, T. Takata, T. Sugihara, Tomomitsu Matono +9 more
2019International Journal of Molecular Sciences44 citations Open access
Semantic Scholar
Falsely Elevated Serum Vitamin B12 Levels Were Associated with the Severity and Prognosis of Chronic Viral Liver Disease.
T. Sugihara, M. Koda, T. Okamoto, Kenichi Miyoshi +6 more
2017Yonago acta medica38 citations
Semantic Scholar
Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2
K. Irungbam, Y. Churin, Tomomitsu Matono, J. Weglage +6 more
2019Laboratory Investigation37 citations Open access
Semantic Scholar
Usefulness of contrast‐enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B‐mode ultrasound
Manabu Kishina, M. Koda, Shiho Tokunaga, K. Miyoshi +5 more
2015Hepatology Research37 citations
Semantic Scholar
Left Renal Cortical Thickness Measured by Ultrasound Can Predict Early Progression of Chronic Kidney Disease
T. Takata, M. Koda, T. Sugihara, S. Sugihara +12 more
2015Nephron37 citations
Semantic Scholar
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function
A. Hiraoka, T. Kumada, T. Tada, M. Hirooka +39 more
2023Oncology35 citations
Semantic Scholar
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background
Y. Churin, M. Roderfeld, J. Stiefel, T. Würger +11 more
2014PLoS ONE31 citations Open access
Semantic Scholar
Renal shear wave velocity by acoustic radiation force impulse did not reflect advanced renal impairment
T. Takata, M. Koda, T. Sugihara, S. Sugihara +10 more
2016Nephrology27 citations Open access
Semantic Scholar
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab
A. Hiraoka, T. Kumada, T. Tada, M. Hirooka +38 more
2023Hepatology Research24 citations Open access
Semantic Scholar
Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice.
T. Onoyama, M. Koda, T. Okamoto, Manabu Kishina +3 more
2015Molecular Medicine Reports23 citations Open access
Semantic Scholar
Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
M. Koda, Shiho Tokunaga, T. Okamoto, Masanori Hodozuka +12 more
2015Journal of Hepatology23 citations
Semantic Scholar
Serum Procalcitonin in Patients with Acute Liver Failure.
T. Sugihara, M. Koda, T. Okamoto, Kenichi Miyoshi +5 more
2017Yonago acta medica21 citations
Semantic Scholar
Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner
T. Hasegawa, T. Sugihara, Yoshiki Hoshino, Ryohei Tarumoto +6 more
2021Oncology Letters20 citations Open access
Semantic Scholar
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
T. Tada, T. Kumada, A. Hiraoka, K. Kariyama +36 more
2022Oncology19 citations
Semantic Scholar
Shewanella algae Bacteremia in an End-stage Renal Disease Patient: A Case Report and Review of the Literature
T. Takata, H. Chikumi, Shota Morishita, S. Hamada +7 more
2017Internal medicine19 citations Open access
Semantic Scholar
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients
T. Hatanaka, S. Kakizaki, Atsushi Hiraoka, T. Tada +39 more
2024Alimentary Pharmacology and Therapeutics18 citations
Semantic Scholar
Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice
Atsushi Hiraoka, T. Tada, M. Hirooka, K. Kariyama +44 more
2024Hepatology Research18 citations Open access
Semantic Scholar
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model.
T. Okamoto, M. Koda, K. Miyoshi, T. Onoyama +7 more
2016World Journal of Hepatology18 citations Open access
Semantic Scholar
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial
T. Tada, T. Kumada, Atsushi Hiraoka, M. Hirooka +39 more
2024Alimentary Pharmacology and Therapeutics17 citations
Semantic Scholar
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
H. Ohama, Atsushi Hiraoka, T. Tada, M. Hirooka +39 more
2023Oncology16 citations
Semantic Scholar
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
Kazunari Tanaka, K. Tsuji, Atsushi Hiraoka, T. Tada +40 more
2023Cancers14 citations Open access
Semantic Scholar
Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model.
Ran Nagahara, Tomomitsu Matono, T. Sugihara, Yukako Matsuki +7 more
2019Yonago acta medica12 citations Open access
Semantic Scholar
Utility of virtual touch quantification in the diagnosis of pancreatic ductal adenocarcinoma.
T. Onoyama, M. Koda, Y. Fujise, T. Takata +10 more
2017Clinical imaging12 citations
Semantic Scholar
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma
H. Ohama, Atsushi Hiraoka, T. Tada, M. Hirooka +40 more
2024Cancer Reports11 citations Open access
Semantic Scholar
Association of liver stiffness and steatosis with hepatocellular carcinoma development in patients with hepatitis C virus infection who received direct‐acting antiviral therapy and achieved sustained virological response
T. Tada, Takashi Nishimura, Tomomitsu Matono, Masahiro Yoshida +9 more
2021Hepatology Research11 citations
Semantic Scholar
Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.
T. Sugihara, M. Koda, Tomomitsu Matono, K. Okamoto +3 more
2017Yonago acta medica10 citations Open access
Semantic Scholar
Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study
T. Hatanaka, Y. Yata, Atsushi Hiraoka, T. Tada +44 more
2025Liver international (Print)9 citations
Semantic Scholar
Reliable Performance of mALBI Grade‐Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First‐Line Treatment: Comparative Analysis of 13 Risk Models
T. Hatanaka, S. Kakizaki, Atsushi Hiraoka, T. Tada +37 more
2025Journal of Gastroenterology and Hepatology9 citations
Semantic Scholar
The Natural History and Management of Hepatic Hemangioma
Shigeo Maruyama, Tomomitsu Matono, Masahiko Koda
2023Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma
T. Tada, T. Kumada, Atsushi Hiraoka, M. Hirooka +40 more
2023Liver international (Print)9 citations
Semantic Scholar
Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals
I. Hidaka, M. Enomoto, Syuichi Sato, A. Suetsugu +8 more
2021Internal medicine9 citations Open access
Semantic Scholar
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices
F. Tada, A. Hiraoka, T. Tada, M. Hirooka +40 more
2023Journal of gastroenterology8 citations
Semantic Scholar
Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors
S. Maruyama, Tomomitsu Matono, M. Koda
2022Journal of Clinical Medicine7 citations Open access
Semantic Scholar
Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease
K. Okamoto, Masahiko Koda, T. Okamoto, T. Onoyama +16 more
2019bioRxiv7 citations Open access
Semantic Scholar
Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real‐World Study
H. Ohama, Atsushi Hiraoka, T. Tada, Masashi Hirooka +53 more
2026Hepatology Research6 citations
Semantic Scholar
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real‐World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka +53 more
2026Journal of Gastroenterology and Hepatology6 citations
Semantic Scholar
Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma
Kazunari Tanaka, K. Tsuji, Atsushi Hiraoka, T. Tada +46 more
2025Liver Cancer6 citations Open access
Semantic Scholar
Impact of time‐of‐day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study
A. Naganuma, S. Kakizaki, T. Hatanaka, Atsushi Hiraoka +44 more
2025Hepatology Research6 citations
Semantic Scholar
Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
Tomomitsu Matono, T. Tada, T. Kumada, Atsushi Hiraoka +46 more
2025Hepatology Research6 citations Open access
Semantic Scholar
Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis
T. Hatanaka, N. Saito, S. Kakizaki, Atsushi Hiraoka +19 more
2024Oncology6 citations
Semantic Scholar
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
K. Nouso, Shohei Shiota, Rio Fujita, A. Wakuta +29 more
2023Cancer Medicine6 citations Open access
Semantic Scholar
Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model.
M. Yamane, Tomomitsu Matono, J. Okano, Ran Nagahara +7 more
2019Yonago acta medica6 citations Open access
Semantic Scholar
Two patterns of contrast-enhanced ultrasonography with Sonazoid® in spontaneous rupture of hepatocellular carcinoma: a report of four cases
T. Sugihara, M. Koda, T. Okamoto, Kenichi Miyoshi +2 more
2018Journal of medical ultrasonics6 citations
Semantic Scholar
Metabolic dysfunction‐associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis
Natsuko Kobayashi, T. Tada, Takashi Nishimura, Tomomitsu Matono +9 more
20245 citations
Semantic Scholar
Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
T. Tada, T. Kumada, A. Hiraoka, M. Hirooka +36 more
2023Journal of Gastroenterology and Hepatology5 citations
Semantic Scholar
Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice
D. Zahner, Hannah Glimm, Tomomitsu Matono, Y. Churin +8 more
2017OncoTarget5 citations Open access
Semantic Scholar
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, M. Hirooka +53 more
2026Liver international (Print)4 citations
Semantic Scholar
Lymphocyte–Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis
Tatsuya Sakane, Toshifumi Tada, Hiroshi Tei, Saeko Kushida +22 more
2025Hepatology Research4 citations
Semantic Scholar
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient
Atsushi Hiraoka, Masatoshi Kudo, T. Tada, T. Hatanaka +44 more
2025Oncology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kariyama×24
Invite
K. Kariyama — researcher profile on SciRah
A. Tsutsui×24
Invite
A. Tsutsui — researcher profile on SciRah
K. Takaguchi×24
Invite
K. Takaguchi — researcher profile on SciRah
J. Tani×24
Invite
J. Tani — researcher profile on SciRah

×24

Invite

T. Kumada — researcher profile on SciRah

Invite

C. Ogawa — researcher profile on SciRah

E. Itobayashi×23

Invite

E. Itobayashi — researcher profile on SciRah

T. Hatanaka×23

Invite

T. Hatanaka — researcher profile on SciRah

Invite

K. Kawata — researcher profile on SciRah

M. Atsukawa×22

Invite

M. Atsukawa — researcher profile on SciRah

Invite

K. Tsuji — researcher profile on SciRah

Invite

K. Tajiri — researcher profile on SciRah